CN Patent

CN102940878A — 脊柱髓核植入物

Assigned to Bionet Pharma GmbH · Expires 2013-02-27 · 13y expired

What this patent protects

本发明涉及用于治疗椎间盘的脊柱髓核植入物和因此特别地涉及CD-RAP蛋白的用途。

USPTO Abstract

本发明涉及用于治疗椎间盘的脊柱髓核植入物和因此特别地涉及CD-RAP蛋白的用途。

Drugs covered by this patent

patiromer-sorbitex-calcium (PATIROMER SORBITEX CALCIUM)

Patent Metadata

Patent number: CN102940878A
Jurisdiction: CN
Classification: —
Expires: 2013-02-27
Drug substance claim: No
Drug product claim: No
Assignee: Bionet Pharma GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.